133 related articles for article (PubMed ID: 2041400)
21. Current status of immunoscintigraphy in colorectal cancer--results of 5 years' clinical experiences.
Hölting T; Schlag P; Georgi P
Eur J Surg Oncol; 1990 Aug; 16(4):312-8. PubMed ID: 2199223
[TBL] [Abstract][Full Text] [Related]
22. Immunoscintigraphy of colorectal cancer with an antibody to epithelial membrane antigen (EMA).
Yiu CY; Baker LA; Davidson BR; Ward M; Roberts K; Clarke G; Ward C; Westwood J; Boulos PB; Clark CG
Dis Colon Rectum; 1990 Feb; 33(2):122-6. PubMed ID: 2404713
[TBL] [Abstract][Full Text] [Related]
23. Immunoscintigraphy using 99mTc-labeled anti-CEA monoclonal antibody for patients with colorectal cancer.
Takenoshita S; Hashizume T; Asao T; Nakamura J; Katoh R; Oriuchi N; Ootake H; Inoue T; Watanabe N; Endo K
Anticancer Res; 1995; 15(2):471-5. PubMed ID: 7763024
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunoscintigraphy of colorectal carcinomas with three different radiopharmaceuticals.
Obradovic V; Artiko V; Petrovic M; Lausevic Z; Stojkovic M; Sobic-Saranovic D; Petrovic N; Vlajkovic M; Krivokapic Z
Neoplasma; 2006; 53(5):444-9. PubMed ID: 17013541
[TBL] [Abstract][Full Text] [Related]
25. [Radioimmunoscintigraphy of colorectal tumors with 99m-Tc marked CEA antibodies. Indications and clinical value].
Barzen G; Martini I; Schulz W; Löhde E; Böse-Landgraf J; Richter W; Langer M; Felix R
Med Klin (Munich); 1992 Aug; 87(8):395-402. PubMed ID: 1406470
[TBL] [Abstract][Full Text] [Related]
26. [Radioimmunoscintigraphy with monoclonal antibodies in recurrences and metastases of colorectal tumors].
Roveda L
Medicina (Firenze); 1990; 10(2):160-1. PubMed ID: 2273952
[TBL] [Abstract][Full Text] [Related]
27. [Immunoscintigraphy with a technetium 99m-labeled monoclonal antibody in patients with melanoma].
Dudczak R; Kletter K; Bailer H; Kokoschka E; Pohl-Markl H
Wien Klin Wochenschr; 1987 Apr; 99(7):232-9. PubMed ID: 3590802
[TBL] [Abstract][Full Text] [Related]
28. [The clinical relevance of anti-CEA immunoscintigraphy with the 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies].
Hach A; Wittig B; Piepenburg R; Steinert H; Lahmann C; Dippold W; Hahn K
Rofo; 1992 Jul; 157(1):3-10. PubMed ID: 1638001
[TBL] [Abstract][Full Text] [Related]
29. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
[TBL] [Abstract][Full Text] [Related]
30. [Immunoscintigraphy with radionuclide-labeled monoclonal antibodies for tumor diagnosis and in benign diseases].
Baum RP; Hertel A; Hör G
Immun Infekt; 1989 Feb; 17(1):22-4. PubMed ID: 2647623
[TBL] [Abstract][Full Text] [Related]
31. [Immunoscintigraphy with MAb B72.3 for preoperative detection of lymph node metastases of colorectal carcinoma].
Mörschel M; Bockisch A; Junginger T
Chirurg; 1995 May; 66(5):503-6. PubMed ID: 7607013
[TBL] [Abstract][Full Text] [Related]
32. [Immunoscintigraphic follow-up studies with the 99m-Tc marked monoclonal anti-CEA antibody BW 431/26].
Fritzsche H
Acta Med Austriaca; 1990; 17(2-3):44-6. PubMed ID: 2220267
[TBL] [Abstract][Full Text] [Related]
33. 99mTc-labeled monoclonal anti-carcinoembryonic antigen antibody (BW 431/26). Clinical results in the detection of colorectal carcinomas and recurrences.
Lind P; Langsteger W; Költringer P; Lechner P; Beham A; Arian Schad K; Eber O
Scand J Gastroenterol; 1989 Dec; 24(10):1205-11. PubMed ID: 2602902
[TBL] [Abstract][Full Text] [Related]
34. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
[TBL] [Abstract][Full Text] [Related]
35. Radioimmunodetection of colorectal carcinoma.
Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
[TBL] [Abstract][Full Text] [Related]
36. Anticarcinoembryonic antigen immunoscintigraphy with a 99mTc-Fab' fragment (Immu 4) in primary and recurrent colorectal cancer. A prospective study.
Lechner P; Lind P; Binter G; Cesnik H
Dis Colon Rectum; 1993 Oct; 36(10):930-5. PubMed ID: 8404384
[TBL] [Abstract][Full Text] [Related]
37. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.
Collier BD; Abdel-Nabi H; Doerr RJ; Harwood SJ; Olsen J; Kaplan EH; Winzelberg GG; Grossman SJ; Krag DN; Mitchell EP
Radiology; 1992 Oct; 185(1):179-86. PubMed ID: 1523304
[TBL] [Abstract][Full Text] [Related]
38. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
[TBL] [Abstract][Full Text] [Related]
39. Immunoscintigraphy with a new indium-111-labeled monoclonal antibody (MAb 1A3) in patients with colorectal cancer.
Philpott GW; Siegel BA; Schwarz SW; Connett JM; Rocque PA; Fleshman JW; Wallis JW; Baumann M; Sun Y; Martell AE
Dis Colon Rectum; 1994 Aug; 37(8):782-92. PubMed ID: 8055723
[TBL] [Abstract][Full Text] [Related]
40. Immunoscintigraphy in the follow-up of patients operated on for carcinoma of the sigmoid and rectum. Preliminary report with a new monoclonal antibody: B72.3.
Renda A; Salvatore M; Sava M; Landi R; Lastoria S; Coppola L; Schlom J; Colcher D; Zannini G
Dis Colon Rectum; 1987 Sep; 30(9):683-6. PubMed ID: 3304885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
